Healthcare Triangle, Inc.
HCTI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $12 | $33 | $46 | $35 |
| % Growth | -64.8% | -27.6% | 30.1% | – |
| Cost of Goods Sold | $9 | $26 | $35 | $25 |
| Gross Profit | $3 | $7 | $11 | $11 |
| % Margin | 24.7% | 20.4% | 24.6% | 29.8% |
| R&D Expenses | $0 | $1 | $6 | $5 |
| G&A Expenses | $4 | $5 | $6 | $4 |
| SG&A Expenses | $6 | $10 | $12 | $9 |
| Sales & Mktg Exp. | $2 | $5 | $7 | $5 |
| Other Operating Expenses | $1 | $7 | $3 | $1 |
| Operating Expenses | $8 | $18 | $22 | $16 |
| Operating Income | -$5 | -$11 | -$10 | -$5 |
| % Margin | -40.6% | -34.2% | -22.7% | -15.2% |
| Other Income/Exp. Net | -$1 | -$1 | $1 | -$1 |
| Pre-Tax Income | -$6 | -$12 | -$10 | -$6 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$12 | -$10 | -$6 |
| % Margin | -51% | -37.2% | -20.9% | -16.9% |
| EPS | -281.584 | -517.527 | -966.643 | -503.453 |
| % Growth | 45.6% | 46.5% | -92% | – |
| EPS Diluted | -281.584 | -517.527 | -966.643 | -503.453 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $1 |
| Depreciation & Amortization | $1 | $7 | $3 | $1 |
| EBITDA | -$4 | -$4 | -$6 | -$4 |
| % Margin | -33% | -12.4% | -13% | -11.2% |